当前位置: X-MOL 学术Lancet Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Advances in multiple sclerosis: from reduced relapses to remedies
The Lancet Neurology ( IF 48.0 ) Pub Date : 2018-01-01 , DOI: 10.1016/s1474-4422(17)30417-9
Peter A Calabresi

10 www.thelancet.com/neurology Vol 17 January 2018 outcome measures in patients with Parkinson’s disease. This study expands the evidence from previous smaller studies and opens the field to a broader use of televisits for efficient delivery of care in Parkinson’s disease, including for underserved communities, and potentially for clinical research visits. However, a change of policies for reimbursements of televisits will be required before this approach can be fully implemented in the USA.

中文翻译:

多发性硬化症的进展:从减少复发到治疗

10 www.thelancet.com/neurology Vol 2018 年 1 月 17 日帕金森病患者的结果测量。这项研究扩展了之前小型研究的证据,并为更广泛地使用远程访问打开了领域,以有效地提供帕金森病的护理,包括服务不足的社区,并可能用于临床研究访问。然而,在这种方法在美国全面实施之前,需要改变电视访问报销的政策。
更新日期:2018-01-01
down
wechat
bug